Xiaobin Chen - Publications

Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysis.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 04, 2025

Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy-proven node-positive breast cancer: A prospective study.

Journal: Cancer

Published: March 27, 2025

Timing of surgery and 1-year postoperative outcomes in patients with breast cancer and preoperative COVID-19 history: A matched, longitudinal, ambidirectional cohort study.

Journal: International journal of cancer

Published: November 08, 2024

Expression and Subtype Discordance Between Core Needle Biopsy and Surgical Specimen in Breast Cancer.

Journal: The Journal of surgical research

Published: September 02, 2024

Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study.

Journal: Frontiers in immunology

Published: July 17, 2024

Identification of sequence polymorphism in the D-loop region of mitochondrial DNA as a risk factor for breast cancer.

Journal: Cancer science

Published: April 01, 2024

MAZ-mediated up-regulation of BCKDK reprograms glucose metabolism and promotes growth by regulating glucose-6-phosphate dehydrogenase stability in triple-negative breast cancer.

Journal: Cell death & disease

Published: January 11, 2024

YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathway.

Journal: Biology direct

Published: December 24, 2023

Prognostic Value of Immunohistochemistry-based Subtyping Before and After Neoadjuvant Chemotherapy in Patients with Triple-negative Breast Cancer.

Journal: The American journal of surgical pathology

Published: December 20, 2023

High leukocyte mitochondrial DNA copy number contributes to poor prognosis in breast cancer patients.

Journal: BMC cancer

Published: November 22, 2022

Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis.

Journal: NPJ breast cancer

Published: July 08, 2022

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy.

Journal: Pathology oncology research : POR

Published: April 28, 2022